Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. The company's lead radiotherapeutic candidate is rhenium obisbemeda, a ...
Leadership
Marc H. Hedrick M.B.A., M.D.
President, CEO & Director
Andrew J. Sims CPA
VP & CFO
Russ Havranek M.B.A., M.S.
Executive Vice President of Commercial and Corporate Strategy
